Resource Library

The composite measurement concept outlined here may be used as the foundation for future analytical validation, usability, and clinical validation seeking to capture the progression of cardiac function in FD.

The new algorithm may be of use in studies of (central nervous system) CNS disorders, such as Parkinson’s disease.

Summarize the findings from three developmental studies of the Parkinson’s Disease Functional Impacts Digital Instrument (PD-FIDI).

Here, we develop recommendations for digital assessment implementation in PD clinical trials.

Mobile measurements are equivalently reliable to in-clinic measurements.

Remote spirometry data collection is feasible in studies recruiting asthma patients.

Motor symptoms in patients with movement disorders are traditionally measured using clinician and patient reported outcome measures such as the MDS-UPDRS.

The iPhone 8 Plus is suitable for measuring acceleration of gait & balance and postural tremor.

The MDS-UPDRS[1] is considered the gold standard for assessing symptom severity in Parkinson’s disease. This scale assesses multiple aspects of daily living.

10 healthy subjects performed a series of walking tests while wearing 6 ActiGraph GT9X Link devices concurrently, one for each of 6 wear positions.